Keyphrases
Early Breast Cancer
100%
Endocrine Therapy
100%
Prolonged Duration
100%
High Risk
50%
Chemotherapy
50%
Aromatase Inhibitors
50%
Postmenopausal Women
50%
Bone Mineral Density
50%
Disease Risk
50%
Recurrent Disease
50%
Neoadjuvant Endocrine Therapy
50%
Potential Side Effects
50%
Hormonal Therapy
50%
Hormonal Treatment
50%
Tamoxifen Therapy
50%
Optimal Duration
50%
Regional Lymph Node Metastasis
50%
Women with Breast Cancer
50%
INIS
cancer
100%
therapy
100%
breasts
100%
hormones
100%
women
66%
diseases
33%
risks
33%
side effects
33%
density
33%
bones
33%
chemotherapy
33%
lymph nodes
33%
tamoxifen
33%
metastases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Endocrine Therapy
100%
Hormone Cancer Therapy
66%
Side Effect
33%
Recurrent Disease
33%
Chemotherapy
33%
Lymph Node Metastasis
33%
Tamoxifen
33%
Aromatase Inhibitor
33%
Medicine and Dentistry
Breast Cancer
100%
Hormone Therapy
100%
Lymph Node Metastasis
33%
Side Effect
33%
Recurrent Disease
33%
Bone Density
33%
Postmenopause
33%
Aromatase Inhibitor
33%
Tamoxifen
33%
Nursing and Health Professions
Hormonal Therapy
100%
Breast Cancer
100%
Bone Density
33%
Side Effect
33%
Recurrent Disease
33%
Lymph Node Metastasis
33%
Tamoxifen
33%
Aromatase Inhibitor
33%
Immunology and Microbiology
Bone Density
100%
Lymph Node
100%
Postmenopause
100%